Dennis Cho, an officer of Twist Bioscience Corp, filed a Form 144 notice on November 16, 2026, proposing the sale of 5,427 shares of common stock on NASDAQ with an aggregate market value of $562,716.95.

Key Highlights

  • Proposed sale: 5,427 shares of Twist Bioscience Corp common stock, with an aggregate market value of $562,716.95.
  • Source of shares: The shares were acquired on November 12, 2026, through restricted stock vesting from the issuer, classified as compensation.
  • Approximate sale date: November 16, 2026, through Fidelity Brokerage Services LLC.
  • Shares outstanding: 62,707,424 shares of common stock outstanding at the time of the filing.
  • Prior three-month sales: Dennis H. Cho sold a total of 27,026 shares in six separate transactions between August 19, 2026, and November 3, 2026, generating gross proceeds across those transactions.
  • Tax coverage noted: The filing states the sale "includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution."

Twist Bioscience Officer Dennis Cho Proposes Common Stock Sale Following Restricted Stock Vesting

According to the Form 144 filing dated November 16, 2026, Dennis Cho, identified as an officer of Twist Bioscience Corp (NASDAQ:TWST), intends to sell 5,427 shares of the company's common stock. The filing lists Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, as the broker for the proposed transaction. The aggregate market value of the shares to be sold is stated as $562,716.95.

The filing discloses that the 5,427 shares were acquired on November 12, 2026, through a restricted stock vesting transaction from the issuer, with payment characterized as compensation. A remark in the filing states that the sale "includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution," providing context for the proposed transaction.

The filing also reports six sales of Twist Bioscience common stock by Dennis H. Cho during the three months preceding the notice: 14,205 shares on August 19, 2026, for gross proceeds of $1,843,098.75; 1,598 shares on August 21, 2026, for $222,228.11; 412 shares on September 8, 2026, for $50,521.05; 348 shares on September 21, 2026, for $57,591.01; 9,514 shares on October 2, 2026, for $1,797,040.47; and 949 shares on November 3, 2026, for $128,496.21. The total shares outstanding at the time of the filing are reported as 62,707,424.

What Was Disclosed

Twist Bioscience Corp officer Dennis Cho filed a Form 144 on November 16, 2026, disclosing the proposed sale of 5,427 shares of common stock valued at $562,716.95, acquired through restricted stock vesting on November 12, 2026, with a portion intended to cover tax obligations.